Impact of Medicare Drug Price Negotiation on Infusion Centers
Explore how the Medicare Drug Price Negotiation impacts infusion centers in New Mexico, affecting patient access and treatment costs for chronic diseases.
Explore how the Medicare Drug Price Negotiation impacts infusion centers in New Mexico, affecting patient access and treatment costs for chronic diseases.
Analysis reveals higher administrative and financial burdens for Medicare Advantage enrollees with multiple chronic conditions, highlighting the impact of managed care on treatment complexity.
CMS introduces the Ambulatory Specialty Model, a new mandatory payment model for specialists treating low back pain and heart failure, effective from 2027 to improve care quality and reduce costs.
Special Needs Plans (SNPs) are driving significant growth in Medicare Advantage enrollment in 2025, with chronic condition and dual-eligible SNPs leading gains. Institutional SNPs decline amid evolving care models.
Congressional consideration of Medicaid cuts threatens primary care continuity, increasing health risks and costs for millions. Stable insurance coverage is key for preventive care and managing chronic diseases.
U.S. cancer death rates declined steadily from 2001 to 2022, including during the pandemic, driven by advances in detection and treatment. Regulatory fraud enforcement and new FDA approvals impact healthcare and insurance sectors.